In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Pyrosequencing buys Personal Chemistry

Executive Summary

Pyrosequencing AB (DNA sequencing technologies and analysis systems) has acquired privately held Personal Chemistry AB (organic chemical synthesis solutions) through the issuance of 23.2mm shares and 11.6mm warrants. One warrant enables the holder to buy one Pyrosequencing common share at $1.97 (SEK16) for up to four years.
Deal Industry
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Biotechnology
    • Drug Discovery Tools
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Intra-Biotech Deal
    • Payment Includes Stock

Related Companies

UsernamePublicRestriction

Register